Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s164281 ◽

2018 ◽

Vol Volume 13 ◽

pp. 1483-1494 ◽

Cited By ~ 4

Author(s):

Edward M Kerwin ◽

Thomas M Siler ◽

Samir Arora ◽

Patrick Darken ◽

Earl St Rose ◽

...

Keyword(s):

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

Respiratory Medicine ◽

10.1016/j.rmed.2019.08.010 ◽

2019 ◽

Vol 158 ◽

pp. 59-66 ◽

Cited By ~ 8

Author(s):

Klaus F. Rabe ◽

Fernando J. Martinez ◽

Gary T. Ferguson ◽

Chen Wang ◽

Dave Singh ◽

...

Keyword(s):

Triple Therapy ◽

Study Protocol ◽

Phase Iii ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Phase Iii Study ◽

Delivery Technology ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study

Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ◽

10.15326/jcopdf.4.1.2016.0158 ◽

2017 ◽

Vol 4 (1) ◽

pp. 21-33 ◽

Cited By ~ 2

Author(s):

Sanjay Sethi ◽

Charles Fogarty ◽

Nicola A. Hanania ◽

Fernando J. Martinez ◽

Stephen Rennard ◽

...

Keyword(s):

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Dose Ranging ◽

Delivery Technology ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD

10.1183/13993003.congress-2018.pa1014 ◽

2018 ◽

Cited By ~ 1

Author(s):

Yasuhiro Gon ◽

Koichi Nishi ◽

Kazuhiro Sato ◽

Andrea Maes ◽

Shahid Siddiqui ◽

...

Keyword(s):

Japanese Patients ◽

Dose Inhaler ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

European Journal of Pharmaceutical Sciences ◽

10.1016/j.ejps.2020.105472 ◽

2020 ◽

Vol 153 ◽

pp. 105472

Author(s):

Samuel Israel ◽

Ashish Kumar ◽

Kiernan DeAngelis ◽

Magnus Aurivillius ◽

Paul Dorinsky ◽

...

Keyword(s):

Dose Inhaler ◽

Metered Dose Inhaler ◽

Healthy Male ◽

Pulmonary Deposition ◽

Metered Dose ◽

Male Subjects ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s171707 ◽

2018 ◽

Vol Volume 13 ◽

pp. 2673-2684 ◽

Cited By ~ 10

Author(s):

Wilfried De Backer ◽

Jan De Backer ◽

Wim Vos ◽

Ilse Verlinden ◽

Cedric Van Holsbeke ◽

...

Keyword(s):

Randomized Study ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Respiratory Research ◽

10.1186/s12931-016-0491-8 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 14

Author(s):

Colin Reisner ◽

Leonardo M. Fabbri ◽

Edward M. Kerwin ◽

Charles Fogarty ◽

Selwyn Spangenthal ◽

...

Keyword(s):

Fixed Dose ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Metered Dose ◽

Dose Combination ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3351 ◽

2019 ◽

Author(s):

G.T. Ferguson ◽

K.F. Rabe ◽

E. Bourne ◽

S. Ballal ◽

K. DeAngelis ◽

...

Keyword(s):

Lung Function ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Delivery Technology ◽

Function Assessment ◽

Formoterol Fumarate

Download Full-text

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s166455 ◽

2018 ◽

Vol Volume 13 ◽

pp. 1965-1977 ◽

Cited By ~ 3

Author(s):

Colin Reisner ◽

James Pearle ◽

Edward M Kerwin ◽

Earl St Rose ◽

Patrick Darken

Keyword(s):

Dose Inhaler ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study

10.1055/s-0039-3403159 ◽

2020 ◽

Author(s):

FJ Martinez ◽

GT Ferguson ◽

E Bourne ◽

S Ballal ◽

P Darken ◽

...

Keyword(s):

Lung Function ◽

Subgroup Analysis ◽

Recent History ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

History Of ◽

Delivery Technology ◽

Formoterol Fumarate

Download Full-text

Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3333 ◽

2019 ◽

Cited By ~ 1

Author(s):

C. Wang ◽

T. Yang ◽

J. Kang ◽

R. Chen ◽

L. Zhao ◽

...

Keyword(s):

Triple Therapy ◽

Chinese Patients ◽

Dose Inhaler ◽

Efficacy And Safety ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Severe Copd ◽

Formoterol Fumarate

Download Full-text

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study

Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study

Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol